Skip to main content
. 2016 Jul;101(7):879–883. doi: 10.3324/haematol.2015.140996

Table 2.

Multivariable analysis of factors determining acquisition of a major clinical response in patients relapsing after an allogeneic transplant for acute myeloid leukemia or myelodysplastic syndrome who were treated with azacitidine.

graphic file with name 101879.tab2.jpg